Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barrier decrease » barrier disease (Expand Search), marked decrease (Expand Search), barrier creates (Expand Search)
larger decrease » marked decrease (Expand Search)
-
2241
-
2242
-
2243
-
2244
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2245
-
2246
-
2247
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2248
-
2249
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2250
-
2251
-
2252
-
2253
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2254
-
2255
-
2256
-
2257
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2258
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2259
-
2260